The Lancet: January 14, 2008
At least 170 million people worldwide are estimated to have diabetes mellitus, and this number is predicted to more than double by 2030. In this week's podcast Professor Colin Baigent from the Cholesterol Treatment Triallists Collaboration at the University of Oxford, UK, discusses a large meta-analysis which shows how people with diabetes can reduce their risk of cardiovascular events from statin therapy in the same way as people without diabetes, regardless of existing cardiovascular disease. He comments that in light of these results, all people with diabetes should be considered for statin treatment. (Source: Listen to The Lancet)
Source: Listen to The Lancet - January 14, 2008 Category: Journals (General) Authors: The Lancet Source Type: podcasts
The Lancet: November 23, 2007
Statins are safe, well tolerated, and have a proven impact on cardiovascular disease, concludes a Review, discussed in this week's podcast by author Jane Armitage, from the University of Oxford, UK . Given at standard daily doses, statins typically reduce blood concentrations of LDL cholesterol by around 30-45% (Source: Listen to The Lancet)
Source: Listen to The Lancet - November 23, 2007 Category: General Medicine Authors: The Lancet Source Type: podcasts
JAMA: 2007-02-14, Vol. 297, No. 6, Author in the Room Audio Interview
Interview with Paul M. Ridker, MD, MPH, author of Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score. Summary Points: 1. Half of all heart attacks and strokes occur among those with normal cholesterol levels and 15-20% occur among those with no major risk factors at all. 2. The major breakthroughs in understanding cardiovascular disease over the past decade include insights about inflammation and genetics. Each of these can easily be ascertained with either a simple blood test (hsCRP for inflammation) or a simple question about parental histo...
Source: JAMA Author in the Room - April 13, 2007 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Two Sides to the Cholesterol Story
Get HDL a lot higher —and LDL even lower. (Source: Cleveland Clinic Health Edge)
Source: Cleveland Clinic Health Edge - January 24, 2007 Category: Consumer Health News Authors: healthedge at ccf.org Tags: Heart Health Source Type: podcasts
Two Sides to the Cholesterol Story
Get HDL a lot higher—and LDL even lower. (Source: Cleveland Clinic Health Edge)
Source: Cleveland Clinic Health Edge - January 24, 2007 Category: Consumer Health News Authors: healthedge at ccf.org Tags: Heart Health Source Type: podcasts
Cholesterol Study
A new---groundbreaking study ---may offer promise in the effort to stop heart disease. A majority of people treated with a high dose cholesterol drug saw plaque build-up in their coronary arteries actually reverse —and without major side effects from taking the higher dose drug. (Source: Cleveland Clinic Health Edge)
Source: Cleveland Clinic Health Edge - March 10, 2006 Category: Consumer Health News Authors: healthedge at ccf.org Tags: Cholesterol Study Source Type: podcasts
Cholesterol Study
A new---groundbreaking study ---may offer promise in the effort to stop heart disease. A majority of people treated with a high dose cholesterol drug saw plaque build-up in their coronary arteries actually reverse—and without major side effects from taking the higher dose drug. (Source: Cleveland Clinic Health Edge)
Source: Cleveland Clinic Health Edge - March 10, 2006 Category: Consumer Health News Authors: healthedge at ccf.org Tags: Cholesterol Study Source Type: podcasts
ASFH: Statins and AMD
Paper Discussed: A case control study of age related macular degeneration and use of statins
L Smeeth, C Cook, U Chakravarthy, R Hubbard, and A E Fletcher
British Journal of Ophthalmology, September 2005; 89: p1171-1175
Guest: Liam Smeeth, Ph.D.
Senior Clinical Lecturer in Epidemiology
London School of Hygiene and Tropical Medicine
University of London
London, England (Source: As Seen From Here)
Source: As Seen From Here - October 2, 2005 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
ASFH: Statins and AMD
Paper Discussed: A case control study of age related macular degeneration and use of statins
L Smeeth, C Cook, U Chakravarthy, R Hubbard, and A E Fletcher
British Journal of Ophthalmology, September 2005; 89: p1171-1175
Guest: Liam Smeeth, Ph.D.
Senior Clinical Lecturer in Epidemiology
London School of Hygiene and Tropical Medicine
University of London
London, England (Source: As Seen From Here)
Source: As Seen From Here - October 2, 2005 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
03-27-05 asfh
Subject: Statins and Age Related Macular Degeneration
Paper Discussed: McGwin G, Xie A, Owsley C
The use of cholesterol-lowering medications and age-related macular degeneration
Ophthalmology (United States), Mar 2005, 112(3) p488-94
Guest: Gerald McGwin, Jr., PhD
Associate Professor of Epidemiology, Department of Ophthalmology
University of Alabama at Birmingham
Subject: Contact Lens Fitting after Refractive Surgery
Paper Discussed: NA
Guest: Irwin Siegel, OD, PhD
Professor of Ophthalmology, NYU School of Medicine (Source: As Seen From Here)
Source: As Seen From Here - March 27, 2005 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
03-27-05 asfh
Subject: Statins and Age Related Macular Degeneration
Paper Discussed: McGwin G, Xie A, Owsley C
The use of cholesterol-lowering medications and age-related macular degeneration
Ophthalmology (United States), Mar 2005, 112(3) p488-94
Guest: Gerald McGwin, Jr., PhD
Associate Professor of Epidemiology, Department of Ophthalmology
University of Alabama at Birmingham
Subject: Contact Lens Fitting after Refractive Surgery
Paper Discussed: NA
Guest: Irwin Siegel, OD, PhD
Professor of Ophthalmology, NYU School of Medicine (Source: As Seen From Here)
Source: As Seen From Here - March 27, 2005 Category: Opthalmology Authors: JYoungMD at gmail.com Source Type: podcasts
